Institutional investors purchased a net $418.5 thousand shares of INO during the quarter ended September 2016, and now own 28.51% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 350.8 Thousand shares of Inovio Pharmaceuticals In...
MORGAN STANLEY & CO. LLC Bought 232.2 Thousand shares of Inovio Pharmaceuticals In...